Expedited FDA designation of breakthrough therapy

Breakthrough Therapy Infographic

Breakthrough therapy designation is a major accomplishment by any drug maker, but what are some of the distinguishing factors that help gain this designation? Learn more about how structural novelty plays a role in this designation and the real-world impact in our latest article.

Related CAS Insights

創薬

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
創薬

ACE2という、疾病病因特定において潜在的に重要なレセプターを標的にする

December 15, 2022

Read article
創薬

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.